[Effect of Quercetin on Wnt/β-Catenin Signal Pathway of K562 and K562R Cells].


Journal

Zhongguo shi yan xue ye xue za zhi
ISSN: 1009-2137
Titre abrégé: Zhongguo Shi Yan Xue Ye Xue Za Zhi
Pays: China
ID NLM: 101084424

Informations de publication

Date de publication:
Oct 2019
Historique:
entrez: 15 10 2019
pubmed: 15 10 2019
medline: 15 11 2019
Statut: ppublish

Résumé

To investigate the effect of Quercetin (Qu) on cell proliferation, apoptosis and cell cycle, as well as the expression changes of Wnt/β-catenin signaling pathway, apoptosis and cell cycle regulators and BCR-ABL in CML susceptible cells K562 and imatinib-resistant cells (IM) K562R. The trypan blue staining was used to detect the all proliferation. The cell cycle and apoptosis were detected by flow cytometry. The fluorescence quantitative PCR and Western blot were used to detect the expression of mRNA and protein respectively. After administration with 5, 10, 20, 40, 80, 160, 320 μmol/L Qu, the inhibition ratio in K562 cells was 5.07%, 5.98%, 11.09%, 31.88%, 56.89%, 70.44%, 86.63%; and that in K562R cells were 4.99%, 9.75%, 10.54%, 8.93%, 25.13%, 46.89%, 68.60%; IC Qu can inhibit the proliferation K562 and K562R cells, and decrease the drug resistance and increase the sensitivity, that relate with inhibiting Wnt/β-catenin signaling pathway, activating apoptosis pathway and cyclins. 槲皮素对K562和K562R细胞Wnt/β-catenin信号通路的影响. 观察槲皮素(Qu)对伊马替尼(IM)敏感细胞K562及耐药细胞K562R的增殖、凋亡、细胞周期的影响,探讨凋亡及细胞周期调控因子、Wnt/β-catenin信号通路及BCR-ABL的表达变化,为Qu的临床应用提供实验室依据. 应用台盼蓝染色法检测K562和K562R细胞的增殖水平;流式细胞术检测细胞凋亡及细胞周期的分布;荧光定量PCR及Western blot法分别检测Wnt/β-catenin信号通路成员、细胞凋亡及细胞周期相关因子的mRNA及蛋白的表达. 经Qu 5、10、20、40、80、160、320 μmol/L作用于K562细胞后,K562细胞抑制率分别为5.07%、5.98%、11.09%、31.88%、56.89%、70.44%、86.63%;K562R细胞抑制率分别为4.99%、9.75%、10.54%、8.93%、25.13%、46.89%、68.60%。K562、K562R的IC Qu能够抑制K562及K562R细胞的增殖,降低其耐药性,增加敏感性,这与Qu抑制Wnt/β-catenin信号通路、激活凋亡途径及细胞周期因子相关.

Autres résumés

Type: Publisher (chi)
槲皮素对K562和K562R细胞Wnt/β-catenin信号通路的影响.

Identifiants

pubmed: 31607291
pii: 1009-2137(2019)05-1409-07
doi: 10.19746/j.cnki.issn.1009-2137.2019.05.009
doi:

Substances chimiques

CTNNB1 protein, human 0
beta Catenin 0
Quercetin 9IKM0I5T1E
Glycogen Synthase Kinase 3 beta EC 2.7.11.1

Types de publication

Journal Article

Langues

chi

Sous-ensembles de citation

IM

Pagination

1409-1415

Auteurs

Wei Li (W)

Harbin Institute of Hematology & Oncology, Harbin 150010, Heilongjiang Province, China.

Ying Zhao (Y)

College of pharmacy, Harbin University of Commerce, Harbin 150010, Heilongjiang Province, China,E-mail: zhaoy0204@163.com.

Lin Qiu (L)

Harbin Institute of Hematology & Oncology, Harbin 150010, Heilongjiang Province, China.

Jun Ma (J)

Harbin Institute of Hematology & Oncology, Harbin 150010, Heilongjiang Province, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH